Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Digestive System Neoplasms

abstract

  • TMTX can be administered at maximal doses in combination with FU and LV without increasing toxicity. The PR rate of 20% in advanced colorectal carcinoma patients previously treated with chemotherapy is encouraging and merits further study.

publication date

  • April 1994

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7512128

Additional Document Info

start page

  • 695

end page

  • 700

volume

  • 12

number

  • 4